Wednesday, 26 August 2026European Markets
ExploreSearch
ViaNews EU
stock

INTEXA Stock Bearish By 15% So Far Today

Loading stream...

(VIANEWS) - Shares of INTEXA (CAC 40: ITXT.PA) slid by a staggering 15.17% to $2.46 at 13:41 EST on Monday, after five successive sessions in a row of losses. CAC 40 is dropping 1.34% to $7,137.10, after two consecutive sessions in a row of gains. This seems, up until now, an all-around down trend exchanging session today.

About INTEXA

Intexa S.A. engages in the operation of the photovoltaic installation of Saint-André-de-Cubzac in France. The company was founded in 2011 and is headquartered in Saint-Etienne, France. Intexa S.A. is a subsidiary of Casino Guichard-Perrachon.

Earnings Per Share

As for profitability, INTEXA has a trailing twelve months EPS of $0.1.

PE Ratio

INTEXA has a trailing twelve months price to earnings ratio of 24.6. Meaning, the purchaser of the share is investing $24.6 for every dollar of annual earnings.

Volume

Today's last reported volume for INTEXA is 70 which is 311.76% above its average volume of 17.

More news about INTEXA (ITXT.PA).

Categories

stock

Tags

INTEXAStock PriceITXT.PAWall StreetPrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com